Christopher Ryan

Professor

  • 4933 Citations
  • 37 h-Index
19982020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Christopher Ryan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 14 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

  • Research Output

    A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

    Patel, S. P., Othus, M., Chae, Y. K., Giles, F. J., Hansel, D. E., Singh, P. P., Fontaine, A., Shah, M. H., Kasi, A., Baghdadi, T. A., Matrana, M., Gatalica, Z., Korn, W. M., Hayward, J., McLeod, C., Chen, H. X., Sharon, E., Mayerson, E., Ryan, C. W., Plets, M. & 2 others, Blanke, C. D. & Kurzrock, R., May 15 2020, In : Clinical Cancer Research. 26, 10, p. 2290-2296 7 p.

    Research output: Contribution to journalArticle

    Open Access
  • 13 Scopus citations

    A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study

    Riedel, R. F., Ballman, K. V., Lu, Y., Attia, S., Loggers, E. T., Ganjoo, K. N., Livingston, M. B., Chow, W., Wright, J., Ward, J. H., Rushing, D., Okuno, S. H., Reed, D. R., Liebner, D. A., Keedy, V. L., Mascarenhas, L., Davis, L. E., Ryan, C., Reinke, D. K. & Maki, R. G., 2020, (Accepted/In press) In : Oncologist.

    Research output: Contribution to journalArticle

    Open Access
  • Deep Functional and Molecular Characterization of a High-Risk Undifferentiated Pleomorphic Sarcoma

    Berlow, N. E., Grasso, C. S., Quist, M. J., Cheng, M., Gandour-Edwards, R., Hernandez, B. S., Michalek, J. E., Ryan, C., Spellman, P., Pal, R., Million, L. S., Renneker, M. & Keller, C., 2020, In : Sarcoma. 2020, 6312480.

    Research output: Contribution to journalArticle

    Open Access
  • Open Access
  • Overall survival and histology-specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

    Patel, S., von Mehren, M., Reed, D. R., Kaiser, P., Charlson, J., Ryan, C. W., Rushing, D., Livingston, M., Singh, A., Seth, R., Forscher, C., D'Amato, G., Chawla, S. P., McCarthy, S., Wang, G., Parekh, T., Knoblauch, R., Hensley, M. L., Maki, R. G. & Demetri, G. D., Aug 1 2019, In : Cancer. 125, 15, p. 2610-2620 11 p.

    Research output: Contribution to journalArticle

    Open Access
  • 5 Scopus citations